Skip to main content
Erschienen in: Digestive Diseases and Sciences 6/2013

01.06.2013 | Original Article

Changes of the Intestinal Microbiota, Short Chain Fatty Acids, and Fecal pH in Patients with Colorectal Cancer

verfasst von: Seiji Ohigashi, Kazuki Sudo, Daiki Kobayashi, Osamu Takahashi, Takuya Takahashi, Takashi Asahara, Koji Nomoto, Hisashi Onodera

Erschienen in: Digestive Diseases and Sciences | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

New molecular biology-based methods of bacterial identification are expected to help elucidate the relationship between colorectal cancer (CRC) and intestinal microbiota. Although there is increasing evidence revealing the potential role of microbiota in CRC, it remains unclear whether microbial dysbiosis is the cause or the result of CRC onset.

Aim

We investigated the changes of intestinal environments in CRC or adenoma.

Methods

We analyzed 13 groups of microbiota, 8 types of organic acids, and pH in feces obtained from the following 3 groups: individuals with CRC, adenoma, and non-adenoma. Ninety-three patients with CRC and 49 healthy individuals (22 with adenoma and 27 without adenoma) were enrolled.

Results

The counts of total bacteria (10.3 ± 0.7 vs. 10.8 ± 0.3 log10 cells/g of feces; p < 0.001), 5 groups of obligate anaerobe, and 2 groups of facultative anaerobes were significantly lower in the CRC group than in the healthy individuals. While the concentrations of short chain fatty acids (SCFAs) were significantly decreased in the CRC group, the pH was increased in the CRC group (7.4 ± 0.8 vs. 6.9 ± 0.6; p < 0.001). Comparison among the CRC, adenoma, and non-adenoma groups revealed that fecal SCFAs and pH in the adenoma group were intermediate to the CRC group and the non-adenoma group. Within the CRC group, no differences in microbiota or organic acids were observed among Dukes stages.

Conclusions

CRC patients showed significant differences in the intestinal environment, including alterations of microbiota, decreased SCFAs, and elevated pH. These changes are not a result of CRC progression but are involved in CRC onset.
Literatur
1.
Zurück zum Zitat Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355–1359.PubMedCrossRef Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355–1359.PubMedCrossRef
2.
Zurück zum Zitat Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010;10:159–169.PubMedCrossRef Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010;10:159–169.PubMedCrossRef
3.
Zurück zum Zitat Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292:1115–1118.PubMedCrossRef Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292:1115–1118.PubMedCrossRef
4.
Zurück zum Zitat Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136:65–80.PubMedCrossRef Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136:65–80.PubMedCrossRef
5.
Zurück zum Zitat Bjorksten B, Sepp E, Julge K, et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol.. 2001;108:516–520.PubMedCrossRef Bjorksten B, Sepp E, Julge K, et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol.. 2001;108:516–520.PubMedCrossRef
6.
Zurück zum Zitat Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–1031.PubMedCrossRef Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–1031.PubMedCrossRef
7.
Zurück zum Zitat Rawls JF. Enteric infection and inflammation alter gut microbial ecology. Cell Host Microbe. 2007;22:73–74.CrossRef Rawls JF. Enteric infection and inflammation alter gut microbial ecology. Cell Host Microbe. 2007;22:73–74.CrossRef
8.
Zurück zum Zitat Matsuki T, Watanabe K, Fujimoto J, et al. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004;70:7220–7228.PubMedCrossRef Matsuki T, Watanabe K, Fujimoto J, et al. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004;70:7220–7228.PubMedCrossRef
9.
Zurück zum Zitat Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635–1638.PubMedCrossRef Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635–1638.PubMedCrossRef
10.
Zurück zum Zitat Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut. 2008;57:1605–1615.PubMedCrossRef Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut. 2008;57:1605–1615.PubMedCrossRef
11.
Zurück zum Zitat Ohara T, Yoshino K, Kitajima M. Possibility of preventing colorectal carcinogenesis with probiotics. Hepatogastroenterology. 2010;57:1411–1415.PubMed Ohara T, Yoshino K, Kitajima M. Possibility of preventing colorectal carcinogenesis with probiotics. Hepatogastroenterology. 2010;57:1411–1415.PubMed
12.
Zurück zum Zitat Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE. 2011;6:e16393.PubMedCrossRef Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE. 2011;6:e16393.PubMedCrossRef
13.
Zurück zum Zitat Scanlan PD, Shanahan F, Clune Y, et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol. 2008;10:789–798.PubMedCrossRef Scanlan PD, Shanahan F, Clune Y, et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol. 2008;10:789–798.PubMedCrossRef
14.
Zurück zum Zitat Matsuda K, Tsuji H, Asahara T, et al. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environental Microbiol.. 2007;73:32–39.CrossRef Matsuda K, Tsuji H, Asahara T, et al. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environental Microbiol.. 2007;73:32–39.CrossRef
15.
Zurück zum Zitat Matsuda K, Tsuji H, Asahara T, et al. Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environental Microbiol.. 2009;75:1961–1969.CrossRef Matsuda K, Tsuji H, Asahara T, et al. Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environental Microbiol.. 2009;75:1961–1969.CrossRef
16.
Zurück zum Zitat Bird AR, Brown IL, Topping DL. Starches, resistant starches, the gut microflora and human health. Curr Issues Intest Microbiol.. 2000;1:25–37.PubMed Bird AR, Brown IL, Topping DL. Starches, resistant starches, the gut microflora and human health. Curr Issues Intest Microbiol.. 2000;1:25–37.PubMed
17.
Zurück zum Zitat Wong JM, de Souza R, Kendall CW, et al. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235–243.PubMedCrossRef Wong JM, de Souza R, Kendall CW, et al. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235–243.PubMedCrossRef
18.
Zurück zum Zitat Tjalsma H, Scholler-Guinard M, Lasonder E, et al. Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis. Int J Cancer. 2006;119:2127–2135.PubMedCrossRef Tjalsma H, Scholler-Guinard M, Lasonder E, et al. Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis. Int J Cancer. 2006;119:2127–2135.PubMedCrossRef
19.
Zurück zum Zitat Ellmerich S, Djouder N, Scholler M, Klein JP. Production of cytokines by monocytes, epithelial and endothelial cells activated by Streptococcus bovis. Cytokine. 2000;12:26–31.PubMedCrossRef Ellmerich S, Djouder N, Scholler M, Klein JP. Production of cytokines by monocytes, epithelial and endothelial cells activated by Streptococcus bovis. Cytokine. 2000;12:26–31.PubMedCrossRef
20.
Zurück zum Zitat Hill MJ, Drasar BS, Hawksworth G, et al. Bacteria and aetiology of cancer of large bowel. Lancet. 1971;1:95–100.PubMedCrossRef Hill MJ, Drasar BS, Hawksworth G, et al. Bacteria and aetiology of cancer of large bowel. Lancet. 1971;1:95–100.PubMedCrossRef
21.
Zurück zum Zitat Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol. 1995;61:3202–3207.PubMed Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol. 1995;61:3202–3207.PubMed
22.
Zurück zum Zitat Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut. 1994;35:S35–S38.PubMedCrossRef Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut. 1994;35:S35–S38.PubMedCrossRef
23.
Zurück zum Zitat Augenlicht LH, Mariadason JM, Wilson A, et al. Short chain fatty acids and colon cancer. J Nutr. 2002;132:3804S–3808S.PubMed Augenlicht LH, Mariadason JM, Wilson A, et al. Short chain fatty acids and colon cancer. J Nutr. 2002;132:3804S–3808S.PubMed
24.
Zurück zum Zitat Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–767.PubMedCrossRef Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–767.PubMedCrossRef
25.
Zurück zum Zitat Johnson IT, Lund EK. Review article: nutrition, obesity and colorectal cancer. Aliment Pharmacol Ther. 2007;26:161–181.PubMedCrossRef Johnson IT, Lund EK. Review article: nutrition, obesity and colorectal cancer. Aliment Pharmacol Ther. 2007;26:161–181.PubMedCrossRef
26.
Zurück zum Zitat Matsubara N. Epigenetic regulation and colorectal cancer. Dis Colon Rectum. 2012;55:96–104.PubMedCrossRef Matsubara N. Epigenetic regulation and colorectal cancer. Dis Colon Rectum. 2012;55:96–104.PubMedCrossRef
27.
Zurück zum Zitat Liu Z, Qin H, Yang Z, et al. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery—a double-blind study. Aliment Pharmacol Ther. 2011;33:50–63.PubMedCrossRef Liu Z, Qin H, Yang Z, et al. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery—a double-blind study. Aliment Pharmacol Ther. 2011;33:50–63.PubMedCrossRef
28.
Zurück zum Zitat Gianotti L, Morelli L, Galbiati F, et al. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J Gastroenterol. 2010;16:167–175.PubMedCrossRef Gianotti L, Morelli L, Galbiati F, et al. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J Gastroenterol. 2010;16:167–175.PubMedCrossRef
29.
Zurück zum Zitat Worthley DL, Le Leu RK, Whitehall VL, et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr. 2009;90:578–586.PubMedCrossRef Worthley DL, Le Leu RK, Whitehall VL, et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr. 2009;90:578–586.PubMedCrossRef
30.
Zurück zum Zitat Quintero E. Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening? Gastroenterol Hepatol. 2009;32:565–576.PubMedCrossRef Quintero E. Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening? Gastroenterol Hepatol. 2009;32:565–576.PubMedCrossRef
31.
Zurück zum Zitat Mueller S, Saunier K, Hanisch C, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol. 2006;72:1027–1033.PubMedCrossRef Mueller S, Saunier K, Hanisch C, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol. 2006;72:1027–1033.PubMedCrossRef
32.
Zurück zum Zitat Zhao L, Xu W, Ibrahim SA, et al. Effects of age and region on fecal microflora in elderly subjects living in Bama, Guangxi. China. Curr Microbiol.. 2011;62:64–70.CrossRef Zhao L, Xu W, Ibrahim SA, et al. Effects of age and region on fecal microflora in elderly subjects living in Bama, Guangxi. China. Curr Microbiol.. 2011;62:64–70.CrossRef
33.
Zurück zum Zitat Cummings JH, Pomare EW, Branch WJ, et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28:1221–1227.PubMedCrossRef Cummings JH, Pomare EW, Branch WJ, et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28:1221–1227.PubMedCrossRef
34.
Zurück zum Zitat Kikuchi H, Yamada T. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats. J Sci Food Agric. 1992;60:139–146.CrossRef Kikuchi H, Yamada T. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats. J Sci Food Agric. 1992;60:139–146.CrossRef
35.
Zurück zum Zitat Matsuki T. Development of quantitative PCR detection method with 16S rRNA gene-targeted genus- and species-specific primers for the analysis of human intestinal microflora and its application. Nippon Saikingaku Zasshi. 2007;62:255–261.PubMedCrossRef Matsuki T. Development of quantitative PCR detection method with 16S rRNA gene-targeted genus- and species-specific primers for the analysis of human intestinal microflora and its application. Nippon Saikingaku Zasshi. 2007;62:255–261.PubMedCrossRef
36.
Zurück zum Zitat Matsuki T, Watanabe K, Tanaka R, et al. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol. 1999;65:4506–4512.PubMed Matsuki T, Watanabe K, Tanaka R, et al. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol. 1999;65:4506–4512.PubMed
37.
Zurück zum Zitat Matsuda K, Tsuji H, Asahara T, et al. Sensitive quantification of Clostridium difficile by reverse transcription—quantitative PCR (RT-qPCR) targeting rRNA molecules. Appl Environ Microbiol. 2012;78:5111–5118.PubMedCrossRef Matsuda K, Tsuji H, Asahara T, et al. Sensitive quantification of Clostridium difficile by reverse transcription—quantitative PCR (RT-qPCR) targeting rRNA molecules. Appl Environ Microbiol. 2012;78:5111–5118.PubMedCrossRef
38.
Zurück zum Zitat Kikuchi E, Miyamoto Y, Narushima S, et al. Design of species-specific primers to identify 13 species of Clostridium harbored in human intestinal tracts. Microbiol Immunol. 2002;46:353–358.PubMed Kikuchi E, Miyamoto Y, Narushima S, et al. Design of species-specific primers to identify 13 species of Clostridium harbored in human intestinal tracts. Microbiol Immunol. 2002;46:353–358.PubMed
Metadaten
Titel
Changes of the Intestinal Microbiota, Short Chain Fatty Acids, and Fecal pH in Patients with Colorectal Cancer
verfasst von
Seiji Ohigashi
Kazuki Sudo
Daiki Kobayashi
Osamu Takahashi
Takuya Takahashi
Takashi Asahara
Koji Nomoto
Hisashi Onodera
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 6/2013
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2526-4

Weitere Artikel der Ausgabe 6/2013

Digestive Diseases and Sciences 6/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.